Login
Companies $RCKT
$2.19 +$0.03 (1.39%) After hours
ROCKET PHARMACEUTICALS, INC. logo

ROCKET PHARMACEUTICALS, INC.

rocketpharma.com

What Do They Do?

Develops genetic therapies for rare, often fatal diseases, focusing on inherited heart disorders and related conditions for patients with these diseases.

How Are They Changing?

Focus on cardiovascular gene therapies The older report describes programs across blood disorders and inherited heart disease, while the latest report prioritizes its AAV cardiovascular platform and deprioritizes further work on its FA and PKD programs.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support